Model
Edge
Acura Pharmaceuticals, Inc
0001416145
Filing Type
4
Filing Date
3/17/2022
Updated
3/18/22, 10:07 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership